{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:08:05Z","timestamp":1785928085977,"version":"3.56.0"},"reference-count":157,"publisher":"Elsevier","isbn-type":[{"value":"9780128142554","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.pbr.2018.08.005","type":"book-chapter","created":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T09:35:20Z","timestamp":1539336920000},"page":"217-257","source":"Crossref","is-referenced-by-count":54,"title":["Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers"],"prefix":"10.1016","author":[{"given":"John Martin","family":"Corkery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2548","article-title":"Captagon: use and trade in the Middle East","volume":"32","author":"Al-Imam","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0099-9598(01)56005-8","article-title":"Ibogaine: a review","volume":"56","author":"Alper","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0020","series-title":"Ibogaine in opioid detoxification: how do we know it works? How does it work?","author":"Alper","year":"2009"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/105504999305848","article-title":"Treatment of acute opioid withdrawal with ibogaine","volume":"8","author":"Alper","year":"1999","journal-title":"Am. J. Addict."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0030","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1749-6632.2000.tb06687.x","article-title":"Ibogaine in acute opioid withdrawal. An open label case series","volume":"909","author":"Alper","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0035","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0099-9598(01)56018-6","article-title":"A contemporary history of ibogaine in the United States and Europe","volume":"56","author":"Alper","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jep.2007.08.034","article-title":"The ibogaine medical subculture","volume":"115","author":"Alper","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0045","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1556-4029.2011.02008.x","article-title":"Fatalities temporally associated with the ingestion of ibogaine","volume":"57","author":"Alper","year":"2012","journal-title":"J. Forensic Sci."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12012-015-9311-5","article-title":"hERG blockade by iboga alkaloids","volume":"16","author":"Alper","year":"2016","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0055","unstructured":"Amundsen, I.H., 2015. Legemiddelverket: Flere Har F\u00e5tt Hjertestans av Iboga [The Danish Medicines Agency: Several Have Had Cardiac Arrests With Iboga], Verdens Gang AS, Oslo, 16 October, VG. Available at: https:\/\/www.vg.no\/nyheter\/innenriks\/i\/Vmlyl\/legemiddelverket-flere-har-faatt-hjertestans-av-iboga. Accessed 2 June 2018."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0060","unstructured":"Amundsen, I.H., Kristiansen, T., Ensrud, S., 2015. Bente (42) Ville Bli rusfri\u2014D\u00f8de p\u00e5 Sjaman Rehabilitering [Bente (42) Wanted to Become Drug-Free\u2014Died on Shaman Rehabilitation], Verdens Gang AS, Oslo, 15 October, VG. Available at: https:\/\/www.vg.no\/nyheter\/innenriks\/i\/OMAEb\/bente-42-ville-bli-rusfri-doede-paa-sjamanrehabilitering. Accessed 2 June 2018."},{"issue":"10","key":"10.1016\/bs.pbr.2018.08.005_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077262","article-title":"Effect of iboga alkaloids on \u03bc-opioid receptor-coupled G protein activation","volume":"8","author":"Antonio","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/bs.pbr.2018.08.005_bb0070","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/bja\/aet396","article-title":"Growing menace of ibogaine toxicity","volume":"111","author":"Asua","year":"2013","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0099-9598(01)56009-5","article-title":"Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine","volume":"56","author":"Baumann","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0080","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3565(24)29567-7","article-title":"In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats","volume":"297","author":"Baumann","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0085","series-title":"Massage Therapist Died After Spiritual Ceremony","author":"Black","year":"2011"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0090","series-title":"Nouveau M\u00e9dicament Agissant au Niveau du SNC, Anti-Drogue","author":"Bocher","year":"1969"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0095","series-title":"A Magick Life: A Biography of Aleister Crowley","isbn-type":"print","author":"Booth","year":"2000","ISBN":"https:\/\/id.crossref.org\/isbn\/9780340718056"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0100","article-title":"Abstract 85. Ibogaine-associated death in a female heroin addict: forensic and toxicological aspects","author":"Borgusz","year":"1998"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0105","series-title":"F\u00e9ticheurs et M\u00e9dicines Traditionelles du Congo (Brazzaville)","author":"Bouquet","year":"1969"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0099-9598(01)56013-7","article-title":"Sigma receptors and iboga alkaloids","volume":"56","author":"Bowen","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"issue":"11","key":"10.1016\/bs.pbr.2018.08.005_bb0115","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/bs.pbr.2018.08.005_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.5042\/daat.2010.0724","article-title":"Ibogaine therapy in the treatment of opiate dependency","volume":"10","author":"Brackenridge","year":"2010","journal-title":"Drugs Alcohol Today"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0125","doi-asserted-by":"crossref","unstructured":"Brenneisen, R. (1994). Tabernanthe. in H\u00e4nsel, R. Keller, K. Rimpler, H. Schneider, G. (Eds.) Hagers Handbuch der Pharmazeutischen Praxis, fifth ed., vol. 6:890\u2013893. Berlin: Springer. Softcover ISBN: 978-3-642-63390-4. https:\/\/doi.org\/10.1007\/978-3-642-57881-6.","DOI":"10.1007\/978-3-642-57881-6"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13256-015-0731-4","article-title":"\u201cHerbal seizures\u201d\u2014atypical symptoms after ibogaine intoxication: a case report","volume":"9","author":"Breuer","year":"2015","journal-title":"J. Med. Case Rep."},{"issue":"10","key":"10.1016\/bs.pbr.2018.08.005_bb0135","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 Annual report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 29th Annual Report, Case 304","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/15672050113109990001","article-title":"Ibogaine in the treatment of substance dependence","volume":"6","author":"Brown","year":"2013","journal-title":"Curr. Drug Abuse Rev."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0145","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes","volume":"44","author":"Brown","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0150","series-title":"Pharmacognosie, Phytochimie, Plantes M\u00e9dicinales","isbn-type":"print","author":"Bruneton","year":"2009","ISBN":"https:\/\/id.crossref.org\/isbn\/9782743019044"},{"issue":"13","key":"10.1016\/bs.pbr.2018.08.005_bb0155","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/ja00965a039","article-title":"The total synthesis of iboga alkaloids","volume":"88","author":"B\u00fcchi","year":"1966","journal-title":"J. Am. Chem. Soc."},{"issue":"2-3","key":"10.1016\/bs.pbr.2018.08.005_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0014-2999(93)90212-Z","article-title":"Inhibitory effects of ibogaine on cocaine self-administration in rats","volume":"241","author":"Cappendijk","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0165","series-title":"Fake \u2018Experts\u2019 Jailed After Heroin User Dies in Luton Clinic","author":"Carr","year":"2017"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0170","series-title":"Liber Null and Psychonaut: An Introduction to Chaos Magic","isbn-type":"print","author":"Carroll","year":"1987","ISBN":"https:\/\/id.crossref.org\/isbn\/9780877286394"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0175","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1016\/j.drugalcdep.2014.09.126","article-title":"Monitoring marijuana use and risk perceptions with Google Trends data","volume":"146","author":"Cavazos-Rehg","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0180","series-title":"\u2018All My Dreams Now Become Impossible\u2019: Heartbroken Girlfriend Tells of Her Despair After Claiming Boyfriend Died From Taking African Plant Potion to Help Him Kick Drug Addiction a Day After He \u2018Proposed\u2019","author":"Cheer","year":"2015"},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0185","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.forsciint.2007.08.013","article-title":"Determination of ibogaine and noribogaine in biological fluids and hair by LC-MS\/MS after Tabernanthe iboga abuse Iboga alkaloids distribution in a drowning death case","volume":"176","author":"Ch\u00e8ze","year":"2008","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0190","series-title":"International Interest in Ibogaine Study","author":"Chilton-Towle","year":"2014"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0195","series-title":"Two Men Jailed for Supplying Unlicensed Medication to Drug Addicts","author":"Coates-Ledden","year":"2017"},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0200","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/dar.12189","article-title":"Using web searches to track interest in synthetic cannabinoids (a\/k\/a \u2018herbal incense\u2019)","volume":"34","author":"Curtis","year":"2015","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0205","author":"Dardashti"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0210","series-title":"The Ibogaine Story: Report on the Staten Island Project","isbn-type":"print","author":"De Rienzo","year":"1997","ISBN":"https:\/\/id.crossref.org\/isbn\/9781570270291"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0215","series-title":"Noruega Muri\u00f3 Por Ingerir Droga para Tratar Adicci\u00f3n","author":"Delgado","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0220","series-title":"Ibogaine in the Treatment of Alcoholism: A Randomized, Double-Blind, Placebo-Controlled, Escalating-Dose, Phase 2 Trial","author":"dos Santos","year":"2017"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0225","series-title":"Exposed\u2014Drug Programme Bosses Who Administered Fatal Drug on Thai Island Lied to Police","author":"Drummond","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0230","series-title":"Drugs Death on Koh Phangan\u2014Thai Police Now Admit Unusual Circumstances","author":"Drummond","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0235","first-page":"748","article-title":"Sur l\u2019iboga, sur ses propri\u00e9ti\u00e9s excitantes, sa composition, et sur l\u2019alcalo\u00efde nouveau qu\u2019il renforme, l\u2019iboga\u00efne","volume":"133","author":"Dybowski","year":"1901","journal-title":"C. R. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0240","first-page":"64","article-title":"Effect of ibogaine on naloxone-precipitated withdrawal syndrome in chronic morphine-dependent rats","volume":"294","author":"Dzoljic","year":"1988","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0245","series-title":"Ibogaine. European Monitoring Centre for Drugs and Drug Addiction\u2014European Information System and Database on New Drugs (EDND), Lisbon","author":"EMCDDA-EDND","year":"2018"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0250","series-title":"Bwiti: An Ethnography of Religious Imagination in Africa","isbn-type":"print","doi-asserted-by":"crossref","DOI":"10.1515\/9780691196282","author":"Fernandez","year":"1982","ISBN":"https:\/\/id.crossref.org\/isbn\/9780691101224"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0255","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0099-9598(01)56017-4","article-title":"\u201cReturning to the path\u201d: the use of iboga[ine] in an equatorial African ritual context and the binding of time, space, and social relationships","volume":"56","author":"Fernandez","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0260","series-title":"Neuer Zugang zu den Iboga-Alkaloiden","author":"Frauenfelder","year":"1999"},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0265","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/AIA.0b013e3181ff4da0","article-title":"Anesthesia for opiate detoxification and the ibogaine controversy","volume":"49","author":"Gevirtz","year":"2011","journal-title":"Int. Anesthiol. Clin."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0270","series-title":"Drugs of Abuse","isbn-type":"print","author":"Giannini","year":"1997","ISBN":"https:\/\/id.crossref.org\/isbn\/1570660530"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0275","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/j.forsciint.2016.06.014","article-title":"Death related to consumption of Rauvolfia sp. powder mislabeled as Tabernanthe iboga","volume":"266","author":"Gicquel","year":"2016","journal-title":"Forensic Sci. Int."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0280","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1749-6632.1998.tb08237.x","article-title":"Mechanisms of antiaddictive actions of ibogaine","volume":"844","author":"Glick","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1749-6632.2000.tb06677.x","article-title":"Development of novel medications for drug addiction. The legacy of an African shrub","volume":"909","author":"Glick","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0290","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0014-2999(91)90474-5","article-title":"Effects and aftereffects of ibogaine on morphine self-administration in rats","volume":"195","author":"Glick","year":"1991","journal-title":"Eur. J. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/bs.pbr.2018.08.005_bb0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0006-8993(96)00056-X","article-title":"18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats","volume":"719","author":"Glick","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0300","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1749-6632.2000.tb05211.x","article-title":"18-Methoxycoronaridine (18-MC) and ibogaine: comparison of antiaddictive efficacy, toxicity, and mechanisms of action","volume":"914","author":"Glick","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0305","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0099-9598(01)56006-X","article-title":"Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener","volume":"56","author":"Glick","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0310","series-title":"Clinical Guidelines for Ibogaine-Assisted Detoxification","author":"Global Ibogaine Therapy Alliance","year":"2015"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0315","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/jcph.404","article-title":"Ascending-dose study of noribogaine in healthy volunteers: pharmacokinetics, pharmacodynamics, safety, and tolerability","volume":"55","author":"Glue","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0320","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/clpt.1991.131","article-title":"Molecular genetics of the debrisoquin-sparteine polymorphism","volume":"50","author":"Gonzalez","year":"1991","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0325","series-title":"Psychedelic Monographs and Essays","first-page":"70","article-title":"Pharmacodynamie et applications therapeutiques de l'iboga et de l'ibogaine","volume":"vol. 6","author":"Goutarel","year":"1993"},{"issue":"10","key":"10.1016\/bs.pbr.2018.08.005_bb0330","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1080\/15563650.2017.1388087","article-title":"2016 Annual Report of the American Association of Poison Control Centers\u2019 National Poison Data System (NPDS): 34th Annual Report, Case 288","volume":"55","author":"Gummin","year":"2017","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"4","key":"10.1016\/bs.pbr.2018.08.005_bb0335","first-page":"441","article-title":"Action de la tabernanthine sur differents parametres cardiovasculaires chez le rat et chez le chien","volume":"12","author":"Hajo","year":"1981","journal-title":"J. Pharmacol. (Paris)"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0340","series-title":"Ibogaine; Can It Cure Addiction Without the Hallucinogenic Trip?","author":"Hamilton","year":"2010"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0345","series-title":"Dying to Get Clean: Is Ibogaine the Answer to Heroin Addiction?","author":"Hannaford","year":"2017"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0350","first-page":"A1940","article-title":"Ibogaine toxicity in a case of good intentions","volume":"193","author":"Hanneman","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0355","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1523\/JNEUROSCI.3959-04.2005","article-title":"Glial cell line-derived neurotrophic factor mediates the desirable actions of the anti-addiction drug ibogaine against alcohol consumption","volume":"25","author":"He","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0360","series-title":"Notice\u2014Prescription Drug List (PDL): Multiple Additions","author":"Health Canada","year":"2017"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0365","series-title":"Can a Hallucinogen From Africa Cure Addiction?","author":"Hegarty","year":"2012"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0370","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0091-3057(97)00451-6","article-title":"Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus","volume":"59","author":"Helsley","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/bs.pbr.2018.08.005_bb0375","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1080\/15563650.2017.1287372","article-title":"Toxicokinetics of ibogaine and noribogaine in a patient with prolonged multiple cardiac arrhythmias after ingestion of Internet purchased ibogaine","volume":"55","author":"Henstra","year":"2017","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0380","series-title":"Liebesmittel: Eine Darstellung der Geschlechtlichen Reixmittel (Aphrodisiaca)","author":"Hirschfeld","year":"1930"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0385","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1056\/NEJMc0804248","article-title":"Long-QT syndrome induced by the antiaddiction drug ibogaine","volume":"360","author":"Hoelen","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/bs.pbr.2018.08.005_bb0390","doi-asserted-by":"crossref","first-page":"PL119","DOI":"10.1016\/0024-3205(95)02322-4","article-title":"Tissue distribution of ibogaine after intraperitoneal and subcutaneous administration","volume":"58","author":"Hough","year":"1996","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0395","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1358\/mf.2000.22.2.796066","article-title":"Pharmacokinetic characterization of the indole alkaloid ibogaine in rats","volume":"22","author":"Hough","year":"2000","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0400","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1521-0391.2012.00330.x","article-title":"A case of death due to ibogaine use for heroin addiction: case report","volume":"22","author":"Jalal","year":"2013","journal-title":"Am. J. Addict."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0405","unstructured":"Janot, M-M., Goutarel, R., 1957. Derivatives of the Ibogaine Alkaloids. US Patent 2813873 issued 19 November 1957, assigned to Les Laboratoires Gobey. Available at: https:\/\/patentimages.storage.googleapis.com\/bb\/82\/2e\/2196275449d3d4\/US2813873.pdf. Accessed 6 May 2018."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0410","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/1057563029001\/4881","article-title":"Extraction studies of Tabernanthe iboga and Voacanga africana","volume":"16","author":"Jenks","year":"2002","journal-title":"Nat. Prod. Lett."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0415","series-title":"Ann\u00e4herungen: Drogen und Rausch","isbn-type":"print","author":"J\u00fcnger","year":"1970","ISBN":"https:\/\/id.crossref.org\/isbn\/9783129045206"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0420","series-title":"Detox \u2018Wonder\u2019 Drug May Face Ban","author":"Kerr","year":"2001"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0425","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3390\/molecules20022208","article-title":"The anti-addiction drug ibogaine and the heart: a delicate relation","volume":"20","author":"Koenig","year":"2015","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0430","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.taap.2013.05.012","article-title":"Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: a study to assess the drug's cardiac ion channel profile","volume":"273","author":"Koenig","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"7","key":"10.1016\/bs.pbr.2018.08.005_bb0435","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/jat\/30.7.434","article-title":"Distribution of ibogaine and noribogaine in a man following a poisoning involving root bark of the Tabernanthe iboga shrub","volume":"30","author":"Kontrimavici\u016bte","year":"2006","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jchromb.2006.05.035","article-title":"Liquid chromatography-electrospray mass spectrometry determination of ibogaine and noribogaine in human plasma and whole blood. Application to a poisoning involving Tabernanthe iboga root","volume":"843","author":"Kontrimavici\u016bte","year":"2006","journal-title":"J. Chromatogr.B Analyt. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0445","first-page":"21","article-title":"Ibogaine in the 21st Century: Boosters, Tune-Ups and Maintenance","volume":"16","author":"Kroupa","year":"2005","journal-title":"Multidisciplinary Association for Psychedelic Studies"},{"issue":"12","key":"10.1016\/bs.pbr.2018.08.005_bb0450","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/medicina44120123","article-title":"Acute toxicity of ibogaine and noribogaine","volume":"44","author":"Kubiliene","year":"2008","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0455","series-title":"The Internationalization of Ayahuasca","isbn-type":"print","year":"2011","ISBN":"https:\/\/id.crossref.org\/isbn\/9783643901484"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0460","series-title":"De l\u2019iboga et de l\u2019iboga\u00efne, Imprimerie F. Lev\u00e9, Paris. Primary Source Edition","isbn-type":"print","author":"Landrin","year":"1905","ISBN":"https:\/\/id.crossref.org\/isbn\/9781294441069"},{"issue":"4","key":"10.1016\/bs.pbr.2018.08.005_bb0465","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/15563650.2016.1138226","article-title":"How toxic is ibogaine?","volume":"54","author":"Litjens","year":"2016","journal-title":"Clin. Toxicol. (Phila.)"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0470","series-title":"Medical Tourist Suffered Ibogaine Death in Costa Rica","author":"Lopez","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0475","author":"Lotsof"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0480","first-page":"19","article-title":"Ibogaine in the treatment of chemical dependence disorders: clinical perspectives","volume":"5","author":"Lotsof","year":"1995","journal-title":"MAPS Bull."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0485","series-title":"Manual for Ibogaine Therapy Screening, Safety, Monitoring & Aftercare. Second Revision","author":"Lotsof","year":"2003"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0490","series-title":"Manual for Ibogaine Therapy: Screening, Safety, Monitoring, and Aftercare","author":"Lotsof","year":"2002"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0495","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/0960327107087802","article-title":"Ibogaine, an anti-addictive drug: pharmacology and time to go further in development. A narrative review","volume":"27","author":"Maciulaitis","year":"2008","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0500","series-title":"Methods and Compositions for Reducing Tolerance to Opioid Analgesics Using Ibogaine and Derivatives Thereof","author":"Maillet","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0505","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuropharm.2015.08.032","article-title":"Noribogaine is a G-protein biased \u03ba-opioid receptor agonist","volume":"99","author":"Maillet","year":"2015","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0510","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0091-3057(03)00119-9","article-title":"Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment","volume":"75","author":"Maisonneuve","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0515","first-page":"1","article-title":"Changes in withdrawal and craving scores in participants undergoing opioid detoxification utilizing ibogaine","volume":"2","author":"Malcolm","year":"2018","journal-title":"J. Psychoactive Drugs"},{"issue":"3 Special issue","key":"10.1016\/bs.pbr.2018.08.005_bb0520","first-page":"231","article-title":"Ibogaine related fatality","volume":"14","author":"Marker","year":"2002","journal-title":"Ann. Toxicol. Anal."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0525","series-title":"Noribogaine in the Treatment of Pain and Drug Addiction","author":"Mash","year":"1997"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0530","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/0024-3205(95)00273-9","article-title":"Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin","volume":"57","author":"Mash","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0535","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.1998.tb08242.x","article-title":"Medication development of ibogaine as a pharmacotherapy for drug dependence","volume":"844","author":"Mash","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0540","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures","volume":"914","author":"Mash","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0545","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0099-9598(01)56012-5","article-title":"Ibogaine in the treatment of heroin withdrawal","volume":"56","author":"Mash","year":"2001","journal-title":"Alkaloids Chem. Biol."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0550","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1051\/ata\/2012001","article-title":"Intoxication mortelle \u00e0 l\u2019iboga: quantification de l\u2019iboga\u00efne et de l\u2019ibogamine dans des racines d\u2019iboga et dans des pr\u00e9l\u00e8vements post-mortem par CPG-SM\/SM","volume":"24","author":"Mazoyer","year":"2012","journal-title":"Ann. Toxicol. Anal."},{"issue":"6","key":"10.1016\/bs.pbr.2018.08.005_bb0555","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/1556-4029.12250","article-title":"Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS\/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material","volume":"58","author":"Mazoyer","year":"2013","journal-title":"J. Forensic Sci."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0560","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/2045125315626073","article-title":"Ibogaine-associated cardiac arrest and death: case report and review of the literature","volume":"6","author":"Meisner","year":"2016","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"1-2","key":"10.1016\/bs.pbr.2018.08.005_bb0565","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0006-8993(96)00739-1","article-title":"Ibogaine neurotoxicity: a re-evaluation","volume":"737","author":"Molinari","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0570","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cobeha.2016.10.009","article-title":"Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use","volume":"13","author":"Morgan","year":"2017","journal-title":"Curr. Opin. Behav. Sci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0575","series-title":"Ibogaine Related Fatalities","author":"Myeboga","year":"2018"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0580","series-title":"The Healing Journey: New Approaches to Consciousness","isbn-type":"print","first-page":"197","article-title":"Ibogaine: fantasy and reality","author":"Naranjo","year":"1974","ISBN":"https:\/\/id.crossref.org\/isbn\/9780394488264"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0585","series-title":"ND-Enabling Studies and GMP Scale-Up of 18-Methoxycoronaridine Hydrochloride (18 MC)","author":"National Institutes of Health","year":"2013"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0590","series-title":"Plant Killed Therapist","author":"Newenham","year":"2011"},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0595","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/00952990.2017.1310218","article-title":"Ibogaine treatment outcomes for opioid dependence from a twelve-month follow-up observational study","volume":"44","author":"Noller","year":"2018","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"10","key":"10.1016\/bs.pbr.2018.08.005_bb0600","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109583","article-title":"The use of Google Trends in health care research: a systematic review","volume":"9","author":"Nuti","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/bs.pbr.2018.08.005_bb0605","first-page":"764","article-title":"Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine","volume":"26","author":"Obach","year":"1998","journal-title":"Drug Metab. Dispos."},{"issue":"7","key":"10.1016\/bs.pbr.2018.08.005_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2014.12.023","article-title":"Internet-purchased ibogaine toxicity confirmed with serum, urine, and product content levels","volume":"33","author":"O'Connell","year":"2015","journal-title":"Am. J. Emerg. Med."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0615","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0306-4522(93)90500-F","article-title":"Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline","volume":"55","author":"O'Hearn","year":"1993","journal-title":"Neuroscience"},{"issue":"22","key":"10.1016\/bs.pbr.2018.08.005_bb0620","doi-asserted-by":"crossref","first-page":"8828","DOI":"10.1523\/JNEUROSCI.17-22-08828.1997","article-title":"The olivocerebellar projection mediates ibogaine-induced degeneration of Purkinje cells: a model of indirect, trans-synaptic excitotoxicity","volume":"17","author":"O'Hearn","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0625","series-title":"Use of Ibogaine for Treating Neuropathic Pain. US Patent 5925634A","author":"Olney","year":"1997"},{"issue":"5","key":"10.1016\/bs.pbr.2018.08.005_bb0630","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/cyber.2014.0486","article-title":"Mind navigators of chemicals' experimenters? A web-based description of e-psychonauts","volume":"18","author":"Orsolini","year":"2015","journal-title":"Cyberpsychol. Behav. Soc. Netw."},{"issue":"5","key":"10.1016\/bs.pbr.2018.08.005_bb0635","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2174\/1570159X15666161111114838","article-title":"Evolutionary considerations on the emerging subculture of the E-psychonauts and the novel psychoactive substances: a comeback to the Shamanism?","volume":"15","author":"Orsolini","year":"2017","journal-title":"Curr. Neuropharmacol."},{"issue":"2-3","key":"10.1016\/bs.pbr.2018.08.005_bb0640","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2004.03.062","article-title":"Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration","volume":"492","author":"Pace","year":"2004","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/bs.pbr.2018.08.005_bb0645","first-page":"422","article-title":"Life-threatening complications of ibogaine: three case reports","volume":"70","author":"Paling","year":"2012","journal-title":"Neth. J. Med."},{"issue":"7","key":"10.1016\/bs.pbr.2018.08.005_bb0650","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jflm.2013.06.032","article-title":"Ibogaine related sudden death: a case report","volume":"20","author":"Papadodima","year":"2013","journal-title":"J. Forensic Leg. Med."},{"issue":"1\u20133","key":"10.1016\/bs.pbr.2018.08.005_bb0655","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejphar.2006.09.008","article-title":"Ibogaine affects brain energy metabolism","volume":"552","author":"Pa\u0161kulin","year":"2006","journal-title":"Eur. J. Pharmacol."},{"issue":"11","key":"10.1016\/bs.pbr.2018.08.005_bb0660","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1358\/dof.1996.021.11.379472","article-title":"Ibogaine, a putatively anti-addictive alkaloid","volume":"21","author":"Popik","year":"1996","journal-title":"Drugs Future"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0665","series-title":"Trippy Mind-Altering African Tribal Drug Killed Addict Trying to Ditch Heroin","author":"Proctor","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0670","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.drugpo.2016.10.006","article-title":"The hidden web and the fentanyl problem: detection of ocfentanil as an adulterant in heroin","volume":"40","author":"Quintana","year":"2017","journal-title":"Int. J. Drug Policy"},{"issue":"3","key":"10.1016\/bs.pbr.2018.08.005_bb0675","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0091-3057(95)00152-M","article-title":"Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats","volume":"52","author":"Rezvani","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0680","series-title":"Death During \u2018Miracle\u2019 Cure Detox","author":"Roden","year":"2015"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0685","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12012-016-9366-y","article-title":"Anti-addiction drug ibogaine prolongs the action potential in human induced pluripotent stem cell-derived cardiomyocytes","volume":"17","author":"Rubi","year":"2017","journal-title":"Cardiovasc. Toxicol."},{"issue":"5051","key":"10.1016\/bs.pbr.2018.08.005_bb0690","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0695","unstructured":"Sandberg, N., 1998. Ibogaine.co.uk Available at: http:\/\/www.ibogaine.co.uk Accessed 15 May 2018."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0700","series-title":"Ibogaine Treatment Centres and Supply Options","author":"Sandberg","year":"2012"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0705","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1749-6632.1996.tb17444.x","article-title":"Ibogaine produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological biomarkers of Purkinje cell loss","volume":"801","author":"Scallet","year":"1996","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"11","key":"10.1016\/bs.pbr.2018.08.005_bb0710","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating drug dependence with the aid of ibogaine: a retrospective study","volume":"28","author":"Schenberg","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0715","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2016.07.005","article-title":"Ibogaine for treating drug dependence. What is a safe dose?","volume":"166","author":"Schep","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"4","key":"10.1016\/bs.pbr.2018.08.005_bb0720","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.pnpbp.2005.11.035","article-title":"Drugs on the web; the Psychonaut 2002 EU project","volume":"30","author":"Schifano","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0725","series-title":"Tabernanthine, Ibogaine Containing Analgesic Compositions","author":"Schneider","year":"1957"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0730","series-title":"Clinic Failed Woman Who Died After Treatment on Experimental Drug","author":"Stewart","year":"2015"},{"issue":"3-4","key":"10.1016\/bs.pbr.2018.08.005_bb0735","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0091-3057(01)00564-0","article-title":"Iboga compounds reverse the behavioural disinhibiting and corticosterone effects of acute methamphetamine: implications for their antiaddictive properties","volume":"69","author":"Szumlinski","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0740","series-title":"Woman Dies While Being Treated for Drug Addiction","author":"Tan","year":"2015"},{"key":"10.1016\/bs.pbr.2018.08.005_bb0745","series-title":"Don\u2019t Let Meth Scene Scare Take Your Son: Mum","author":"Taylor","year":"2016"},{"issue":"5720","key":"10.1016\/bs.pbr.2018.08.005_bb0750","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1126\/science.308.5720.345","article-title":"Addiction research. Ibogaine therapy: a \u2018vast, uncontrolled experiment'","volume":"308","author":"Vastag","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.pbr.2018.08.005_bb0755","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3109\/15563650.2014.927477","article-title":"Cardiac arrest after ibogaine ingestion","volume":"52","author":"Vlaanderen","year":"2014","journal-title":"Clin. Toxicol. (Phila.)"},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0760","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0006-8993(98)00527-7","article-title":"Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats","volume":"800","author":"Wei","year":"1998","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0765","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1556\/2054.01.2017.005","article-title":"Detoxification from methadone using low, repeated, and increasing doses of ibogaine: a case report","volume":"1","author":"Wilkins","year":"2017","journal-title":"J. Psychedelic Stud."},{"issue":"2","key":"10.1016\/bs.pbr.2018.08.005_bb0770","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1874473708666150107120011","article-title":"Psychedelics as medicines for substance abuse rehabilitation: evaluating treatments with LSD, peyote, ibogaine and ayahuasca","volume":"7","author":"Winkelman","year":"2014","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/bs.pbr.2018.08.005_bb0775","series-title":"Ibogaine (aka Eboga): A Journalist Investigates Ibogaine, Its Effects & Its Politics","author":"Witter","year":"1998"},{"issue":"4","key":"10.1016\/bs.pbr.2018.08.005_bb0780","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/hup.2477","article-title":"Detecting a signal in the noise: monitoring the global spread of novel psychoactive substances using media and other open-source information","volume":"30","author":"Young","year":"2015","journal-title":"Hum. Psychopharmacol."},{"issue":"11","key":"10.1016\/bs.pbr.2018.08.005_bb0785","doi-asserted-by":"crossref","first-page":"689","DOI":"10.2165\/11318030-000000000-00000","article-title":"Polymorphism of human cytochrome P450 2D6 and its clinical significance: part I","volume":"48","author":"Zhou","year":"2009","journal-title":"Clin. Pharmacokinet."},{"issue":"1","key":"10.1016\/bs.pbr.2018.08.005_bb0790","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0893-133X(99)00003-2","article-title":"Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain","volume":"21","author":"Zubaran","year":"1999","journal-title":"Neuropsychopharmacology"}],"container-title":["Progress in Brain Research","Psychedelic Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318300979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0079612318300979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:43:04Z","timestamp":1775245384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0079612318300979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128142554"],"references-count":157,"URL":"https:\/\/doi.org\/10.1016\/bs.pbr.2018.08.005","relation":{},"ISSN":["0079-6123"],"issn-type":[{"value":"0079-6123","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}